NeurologyLive® Friday 5 — October 11, 2024

Author(s):

Key Takeaways

Experts developed a clinical program using lecanemab for early Alzheimer’s, highlighting challenges and opportunities in community clinics.
Revised multiple sclerosis diagnostic criteria will incorporate new evidence, biological markers, and advanced MRI findings for earlier, precise diagnoses.
Circadian rhythms' impact on glial function and neuroinflammation in Alzheimer’s is explored, offering clinical insights into disease mechanisms.
New MS diagnostic criteria may improve early detection in patients with overlapping autoimmune conditions through advanced imaging markers.
Spinal muscular atrophy diagnosis updates emphasize newborn screening, early intervention, and evolving classification methods for better patient outcomes.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 11, 2024.

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics

In our latest fall digital issue, a group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.

2: Advancing Multiple Sclerosis Diagnosis With the 2024 Criteria Revision: Xavier Montalban, MD, PhD

The chair of neurology at Hospital Universitari Vall d’Hebron talked about the revision of the MS diagnostic criteria that will integrate new evidence, biological markers, and advanced MRI findings to enable earlier and more precise diagnoses.

3: Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease

Erik Musiek, MD, PhD, a professor of neurology at Washington University in St. Louis, provided clinical insight on a presentation from ANA 2024 highlighting the intricate relationship between circadian rhythms, glial activation, and neuroinflammation in Alzheimer disease.

4: NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria

In our latest Q&A for NeuroVoices, the postdoctoral research assistant at Charité University Berlin discussed how the new diagnostic criteria for multiple sclerosis could offer earlier detection, especially in those with overlapping autoimmune conditions, through advanced imaging markers.

5: Key Updates in SMA Diagnosis: What Clinicians Should Know

In our latest Roundtable Discussion video series episode, a panel of experts delves into the latest updates on spinal muscular atrophy diagnosis, focusing on the critical role of newborn screening, early intervention, and evolving classification methods for improved patient outcomes.